These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 17450268

  • 1. Is there a place for placebo in management of psychogenic movement disorders?
    Lim EC, Ong BK, Seet RC.
    Ann Acad Med Singap; 2007 Mar; 36(3):208-10. PubMed ID: 17450268
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The role of placebo in the diagnosis and treatment of functional neurologic disorders.
    Rommelfanger KS.
    Handb Clin Neurol; 2016 Mar; 139():607-617. PubMed ID: 27719875
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. What is the place for placebo in the management of psychogenic disease?
    Lim EC, Seet RC.
    J R Soc Med; 2007 Feb; 100(2):60-1. PubMed ID: 17277261
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A case of psychogenic tremor associated with blepharospasm and myoclonus: an analysis with surface electromyogram.
    Oide T, Ohara S, Hayashi R.
    Electromyogr Clin Neurophysiol; 2004 Feb; 44(1):39-42. PubMed ID: 15008024
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The patient's perspective of placebo use in daily practice: a qualitative study.
    Tandjung R, Tang H, Fässler M, Huber CA, Rosemann T, Fent R, Badertscher N.
    Swiss Med Wkly; 2014 Feb 13; 144():w13899. PubMed ID: 24526325
    [Abstract] [Full Text] [Related]

  • 10. Functional Movement Disorders and Placebo: A Brief Review of the Placebo Effect in Movement Disorders and Ethical Considerations for Placebo Therapy.
    Kaas BM, Humbyrd CJ, Pantelyat A.
    Mov Disord Clin Pract; 2018 Feb 13; 5(5):471-478. PubMed ID: 30515436
    [Abstract] [Full Text] [Related]

  • 11. Maximizing placebo response in neurological clinical practice.
    Mariani LL, Corvol JC.
    Int Rev Neurobiol; 2020 Feb 13; 153():71-101. PubMed ID: 32563294
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The power of the placebo.
    Eccles R.
    Curr Allergy Asthma Rep; 2007 May 13; 7(2):100-4. PubMed ID: 17437679
    [Abstract] [Full Text] [Related]

  • 14. Psychogenic movement disorders: an unusual presentation in childhood with improvement after placebo test.
    Scola RH, Lorenzoni PJ, Kay CS, Teive HA, Bruck I, Werneck LC.
    Arq Neuropsiquiatr; 2014 Sep 13; 72(9):738-9. PubMed ID: 25252240
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. The clinical use of placebos. Is it ethical? Not when it involves deceiving patients.
    Grace PJ.
    Am J Nurs; 2006 Feb 13; 106(2):58-61. PubMed ID: 16452858
    [No Abstract] [Full Text] [Related]

  • 17. Regulating the placebo effect in clinical practice.
    Chan TE.
    Med Law Rev; 2015 Feb 13; 23(1):1-26. PubMed ID: 25227708
    [Abstract] [Full Text] [Related]

  • 18. Psychogenic tics: diagnostic value of the placebo test.
    Tan EK.
    J Child Neurol; 2004 Dec 13; 19(12):976-7. PubMed ID: 15704874
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.